Microfluidic Chip for Antibiotic Susceptibility Testing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current antibiotic susceptibility testing methods are labor-intensive, time-consuming, and prone to human error, making them inefficient for quickly determining the effectiveness of antibiotics against antibiotic-resistant bacteria, particularly in hospital-acquired infections caused by vancomycin-resistant Enterococcus.

Innovation Solution

An automatic microfluidic system that includes a microfluidic chip with a fluid storage unit, reaction unit, pneumatic micro-pumping unit, and valve units for precise and efficient transportation and mixing of bacterial suspensions and antibiotics, reducing contamination and manual labor, and enabling rapid determination of minimum inhibitory concentrations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional antibiotic susceptibility testing methods are used, then testing can be performed, but the process is labor-intensive and time-consuming

Engineering Contradiction:
Improvetesting efficiencyVSAvoidassay time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The system divides the antibiotic susceptibility testing into multiple parallel reaction chambers, each testing a different antibiotic concentration or combination. This segmentation allows simultaneous processing of multiple samples, reducing total assay time while maintaining comprehensive testing coverage.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent replaces manual mechanical operations (pipetting, mixing, incubation handling) with an automated microfluidic system that uses pneumatic pumps and valves to control fluid flow. This substitution eliminates labor-intensive steps and reduces variability, improving both productivity and time efficiency.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Reliability

If conventional manual testing methods are used, then testing can be performed, but human error and contamination are inevitable

Engineering Contradiction:
Improvetesting accuracyVSAvoidoperational complexity
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The microfluidic system performs self-contained operations including automatic sample loading, reagent dispensing, mixing, and incubation control. The system monitors and manages its own operations through integrated sensors and control mechanisms, eliminating human error while maintaining simplicity through automation.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent introduces a microfluidic chip as an intermediary platform that mediates between the user and the complex testing procedures. The chip integrates all necessary functional elements in a single disposable unit, shielding the user from operational complexity while ensuring reliable and contamination-free testing.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If quantitative testing is performed to determine clinical dosage, then accurate dosing can be achieved, but the process becomes more complicated and labor-intensive

Engineering Contradiction:
Improvedosage determination accuracyVSAvoidtesting procedure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The microfluidic system is designed to perform multiple functions within a single integrated platform: it can test multiple antibiotics, perform serial dilutions, conduct combination testing, and provide quantitative readouts. This multi-functionality achieves comprehensive dosage determination without increasing operational complexity, as all functions are accessed through a unified interface.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system simplifies and accelerates antibiotic susceptibility testing, reducing assay time, increasing reliability, and minimizing human error, thus facilitating quicker and more accurate antibiotic dosing decisions.

Implementation Method 1

a pneumatic micro-pumping unit... for repeatedly and quantitatively transporting the broth and the bacterial suspension to the first reaction chamber to form a first mixing solution

Methodology Applied
Scientific EffectPressure differential: Pressure Gradient

Implementation Method 2

The valve units include a plurality of pneumatic micro-valves and a plurality of valve control air holes. The pneumatic micro-valves are disposed between the fluid storage unit and the pneumatic micro-pumping unit, and between the pneumatic micro-pumping unit and the reaction unit. The valve control air holes are for controlling the opening and closing of the pneumatic micro-valves.

Methodology Applied
Scientific EffectPressure control: Pressure Gradient

Data Source

PatentUS10610863B2Automatic microfluidic system for antibiotic susceptibility testing and method of operating thereof
Publication Date: 2020.04.07 NATIONAL TSING HUA UNIVERSITY
  • US10610863B2 patent drawing
  • US10610863B2 patent drawing
  • US10610863B2 patent drawing

AI summary

An automatic microfluidic system for antibiotic susceptibility testing of the present disclosure at least includes a microfluidic chip. The microfluidic chip includes a fluid storage unit, a reaction unit, a pneumatic micro-pumping unit and a plurality of valve units. The fluid storage unit is provided for storing a bacterial suspension, a broth and an antibiotic solution. The reaction unit includes a first reaction chamber and at least two second reaction chambers. The pneumatic micro-pumping unit is adjacently disposed to the fluid storage unit and the reaction unit for selectively, repeatedly and quantitatively transporting the broth, the bacterial suspension and the antibiotic solution to the reaction unit to form a first mixing solution and at least two second mixing solutions. The valve units include a plurality of pneumatic micro-valves and a plurality of valve control air holes for controlling the opening and closing of the pneumatic micro-valves.